Although other functions of Ubc13 still remain unclear and further investigations are required, Ubc13 may have novel potential as a future target for discovering treatments for insulin resistance, obesity, and type 2 diabetes. Here, UBE2N is linked to obesity due to melanocortin 4 receptor deficiency.